Author: OurCrowd

[OpenEvidence in OpenEvidence] OpenEvidence and Tandem partner to streamline evidence-based prescribing and prior authorizations

MIAMI, FL and NEW YORK, NY — April 2, 2026 — OpenEvidence, the leader in AI-powered medical search and clinical decision support, and Tandem, the leader closing the gap between breakthrough medications and patient access, today announced a strategic partnership to dramatically accelerate how patients access lifesaving medications. Read...

Read More

[InsideTracker in PR Newswire] Landmark study of 20,000 users provides peer-reviewed proof: InsideTracker’s AI health platform linked to significant, sustained health biomarker improvements

CAMBRIDGE, Mass., April 2, 2026 /PRNewswire/ — InsideTracker today announced the publication of a peer-reviewed study in Public Library of Science (PLOS) analyzing longitudinal data from more than 20,000 users on its health AI platform. The retrospective study analyzes one of the largest multimodal, longitudinal datasets in the digital health sector, and found it was associated with measurable improvements in key health indicators across blood and wearable data. This places the company in a class of its own as a health AI partner with peer-reviewed proof of impact. Read more...

Read More